Literature DB >> 8856257

Quenching the thirst in dialysis patients.

S C Dominic1, S Ramachandran, S Somiah, K Mani, S S Dominic.   

Abstract

In a double-blind cross-over trial, 22 stable end-stage renal failure patients on maintenance haemodialysis were subjected to conventional dialysis with dialysate containing 137 mEq/l sodium and constant ultrafiltration (UF) and to a different dialysis therapy, in which, by linear sodium modelling, the dialysate sodium was reduced from 137 to 128 mEq/l. A computerized UF program was used to gradually reduce the UF to a minimum towards the end of the session. Severity of thirst, interdialytic weight gain and intradialytic complications were less with low sodium dialysate. It allowed adequate UF with absolute hemodynamic stability. The reduced incidence of complication with low sodium dialysate therapy was probably because they required less UF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856257     DOI: 10.1159/000189146

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  6 in total

Review 1.  Thirst in patients on chronic hemodialysis: What do we know so far?

Authors:  Maurizio Bossola; Riccardo Calvani; Emanuele Marzetti; Anna Picca; Emanuela Antocicco
Journal:  Int Urol Nephrol       Date:  2020-02-25       Impact factor: 2.370

2.  Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach?

Authors:  Jair Munoz Mendoza; Sumi Sun; Glenn M Chertow; John Moran; Sheila Doss; Brigitte Schiller
Journal:  Nephrol Dial Transplant       Date:  2011-02-08       Impact factor: 5.992

Review 3.  Thirst in critically ill patients: from physiology to sensation.

Authors:  Shoshana Arai; Nancy Stotts; Kathleen Puntillo
Journal:  Am J Crit Care       Date:  2013-07       Impact factor: 2.228

4.  Determinants of thirst distress in patients on hemodialysis.

Authors:  Belgüzar Kara
Journal:  Int Urol Nephrol       Date:  2016-05-23       Impact factor: 2.370

5.  Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass.

Authors:  Joanna Leigh Dunlop; Alain Charles Vandal; Janak Rashme de Zoysa; Ruvin Sampath Gabriel; Imad Adbi Haloob; Christopher John Hood; Philip James Matheson; David Owen Ross McGregor; Kannaiyan Samuel Rabindranath; David John Semple; Mark Roger Marshall
Journal:  BMC Nephrol       Date:  2013-07-15       Impact factor: 2.388

6.  Clinical Effects of Standard and Individualized Dialysate Sodium in Patients on Maintenance Hemodialysis.

Authors:  Natasa Eftimovska-Otovic; Olivera Stojceva-Taneva; Risto Grozdanovski; Saso Stojcev
Journal:  Open Access Maced J Med Sci       Date:  2016-05-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.